JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

JNJ

186.36

+0.12%↑

ABT

125.21

+1.2%↑

TMO

565.31

+0.06%↑

ISRG

538.51

-1.01%↓

DHR

214.15

0%↓

Search

Onconova Therapeutics Inc

Затворен

0

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Onconova Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.11.2025 г., 21:44 ч. UTC

Печалби

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3.11.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3.11.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3.11.2025 г., 23:28 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3.11.2025 г., 23:24 ч. UTC

Печалби

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3.11.2025 г., 23:12 ч. UTC

Печалби

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3.11.2025 г., 23:06 ч. UTC

Пазарно говорене
Печалби

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3.11.2025 г., 22:36 ч. UTC

Пазарно говорене
Печалби

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q EPS $1.49 >FNV

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q Rev $487.7M >FNV

3.11.2025 г., 22:24 ч. UTC

Пазарно говорене

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3.11.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Starbucks Agrees to Sell Stake in China Business -- WSJ

3.11.2025 г., 21:59 ч. UTC

Пазарно говорене

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене
Печалби

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

3.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

3.11.2025 г., 21:49 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3.11.2025 г., 21:40 ч. UTC

Печалби

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3.11.2025 г., 21:31 ч. UTC

Пазарно говорене

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3.11.2025 г., 21:19 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3.11.2025 г., 21:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3.11.2025 г., 21:11 ч. UTC

Печалби

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3.11.2025 г., 21:07 ч. UTC

Печалби

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3.11.2025 г., 21:05 ч. UTC

Печалби

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3.11.2025 г., 21:05 ч. UTC

Печалби

Palantir Technologies 3Q Net $475.6M >PLTR

Сравнение с други в отрасъла

Ценова промяна

Onconova Therapeutics Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Финанси

$

help-icon Live chat